Latest filing published 15 May 2020 for Revance Therapeutics, Inc..
Insider track record
Robert F. Byrnes: trading record in brief
Robert F. Byrnes has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Revance Therapeutics, Inc. and Thermage Inc. Over a trading history stretching from 15 November 2006 to 14 May 2020, the count stands at 13 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 15 May 2020 with a share grant in Revance Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Robert F. Byrnes
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,000 shares0Common StockSEC:0001479290-20-000066:0
- 4,500 shares0Common StockSEC:0001479290-19-000052:0
- 3,000 shares0Common StockSEC:0001479290-18-000076:0
- 3,000 shares0Common StockSEC:0001209191-17-032203:0
- 10,999 shares0Common StockSEC:0001209191-16-103573:0
- 10,999 shares0Common StockSEC:0001209191-16-103573:1
- 4,000 shares@ US$6.6059.7% of flowCommon StockSEC:0001209191-16-099587:0
- 1,666 shares@ US$2.559.6% of flowCommon StockSEC:0001209191-16-099587:1
- 5,333 shares@ US$2.5530.7% of flowCommon StockSEC:0001209191-16-099587:2
- 2,666 shares@ US$3.60Common StockSEC:0001209191-14-058905:0
- 2,666 shares0Common StockSEC:0001209191-14-058905:1
- 2,666 shares0Common StockSEC:0001209191-14-058905:2
- 44,000 sharesCommon StockSEC:0001181431-06-064114:0
13 of 13 declarations
